biomarker

AUSTIN, Texas, July 22, 2026 Natera announced the publication of a prospective, multicenter study in JAMA Dermatology demonstrating that...

LONDON, United Kingdom, July 13, 2026 GSK has announced positive interim results from the registrational Phase II AZUR-1 clinical...

NOVATO, California, July 13, 2026 Lighthouse Pharmaceuticals has announced new clinical findings from its Phase 2/3 GAIN trial, demonstrating...

LUND, Sweden, June 27, 2026 Cantargia AB announced the publication of new preclinical and clinical findings in JCI Insight,...

HOUSTON, Texas, June 22, 2026 Delphi Diagnostics has announced the publication of new clinical findings validating the predictive power...

WALTHAM, Massachusetts, USA, June 2, 202 Stelexis BioSciences has announced encouraging Phase 1 clinical trial results for eganelisib, its...

Dateline IntroductionNovember 17, 2025 — Vancouver, BC & Austin, TX — Augurex Life Sciences Corp. announced the launch of...